Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy for advanced and metastatic Merkel cell ...

The First Nations Investment Forum (FNIF) has unveiled its final program for the inaugural national conference, confirming an exceptional lineup of leaders, investors, and industry experts who are ...

Kids ages 12 to 18 can take part in the Junior Canadian Rangers program, which teaches technical, outdoor and life skills ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." There's nothing more precious ...